Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Get Free Report) have been given an average recommendation of "Hold" by the ten brokerages that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and two have given a buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $30.9250.
SNN has been the subject of a number of recent research reports. JPMorgan Chase & Co. reaffirmed a "neutral" rating on shares of Smith & Nephew SNATS in a research note on Thursday, August 6th. Morgan Stanley reissued an "overweight" rating on shares of Smith & Nephew SNATS in a research report on Wednesday, August 5th. Wall Street Zen raised shares of Smith & Nephew SNATS from a "hold" rating to a "buy" rating in a report on Monday. Kepler Capital Markets cut shares of Smith & Nephew SNATS from a "buy" rating to a "hold" rating in a research report on Thursday, June 4th. Finally, Zacks Research downgraded shares of Smith & Nephew SNATS from a "hold" rating to a "strong sell" rating in a research note on Friday, August 7th.
Read Our Latest Stock Analysis on SNN
Smith & Nephew SNATS Stock Performance
NYSE SNN opened at $29.14 on Friday. The stock's fifty day moving average is $30.24 and its two-hundred day moving average is $31.70. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.14 and a quick ratio of 1.11. Smith & Nephew SNATS has a fifty-two week low of $28.56 and a fifty-two week high of $38.79.
Smith & Nephew SNATS Dividend Announcement
The company also recently declared a dividend, which will be paid on Friday, November 6th. Stockholders of record on Friday, October 2nd will be issued a dividend of $0.312 per share. The ex-dividend date is Friday, October 2nd. This represents a dividend yield of 205.0%.
Hedge Funds Weigh In On Smith & Nephew SNATS
Several large investors have recently modified their holdings of SNN. BlackRock Inc. acquired a new position in shares of Smith & Nephew SNATS in the 2nd quarter worth approximately $505,323,000. River Road Asset Management LLC lifted its stake in Smith & Nephew SNATS by 13.8% during the fourth quarter. River Road Asset Management LLC now owns 3,169,644 shares of the medical equipment provider's stock worth $103,996,000 after purchasing an additional 384,926 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Smith & Nephew SNATS by 5.2% during the fourth quarter. Goldman Sachs Group Inc. now owns 2,053,726 shares of the medical equipment provider's stock worth $67,383,000 after buying an additional 100,697 shares during the period. Bank of America Corp DE acquired a new stake in shares of Smith & Nephew SNATS in the second quarter valued at $97,223,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Smith & Nephew SNATS in the 2nd quarter valued at $89,325,000. Institutional investors and hedge funds own 25.64% of the company's stock.
About Smith & Nephew SNATS
(
Get Free Report)
Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.
In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Smith & Nephew SNATS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew SNATS wasn't on the list.
While Smith & Nephew SNATS currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
